Postulated vasoactive neuropeptide immunopathology affecting the blood–brain/blood–spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?
Donald R Staines1,2, Ekua W Brenu2, Sonya Marshall-Gradisnik21Queensland Health, Gold Coast Population Health Unit, Southport, Gold Coast, Queensland, Australia; 2Faculty of Health Science and Medicine, Population Health and Neuroimmunology Unit, Bond University, Robina, Queensland, AustraliaAbstrac...
Guardado en:
Autores principales: | Sonya Marshall-Gradisnik, Ekua W Brenu, Donald R Staines |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0ce99578f3eb4cef841def4509f74d55 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy?
por: Donald R Staines, et al.
Publicado: (2009) -
Blood–brain barrier: a real obstacle for therapeutics
por: Shiekh FA
Publicado: (2012) -
Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
por: Kanwar JR, et al.
Publicado: (2012) -
Nanocalcium-deficient hydroxyapatite–poly (ε-caprolactone)–polyethylene glycol–poly (ε-caprolactone) composite scaffolds
por: Wang Z, et al.
Publicado: (2012) -
Magnetic nanoformulation of azidothymidine 5’-triphosphate for targeted delivery across the blood–brain barrier
por: Zainulabedin M Saiyed, et al.
Publicado: (2010)